Laurenz Hauptmann
Dr Laurenz Hauptmann, MD is an expert in Cardiology at Medical University of Vienna (Austria). Laurenz Hauptmann has authored 26 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 2 of them ongoing. SLR score: 123 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Public Health - Gastroenterology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2022 - 2026
Number : 26
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy-Reply. PMID 42905680 — cardiovascular diseases, prealbumin, amyloid, tricuspid valve insufficiency, cardiomyopathies, transthyretin amyloid cardiomyopathy | JAMA Cardiol | 2026 | 0 |
| Definition and Prognosis of Mitral Regurgitation in Transthyretin Amyloid Cardiomyopathy: A Multicenter International Cohort Study. PMID 42866868 — heart valve diseases, mortality, cardiovascular system, cohort studies, prealbumin, amyloid, blood circulation, mitral valve insufficiency, prognosis, cardiomyopathies, transthyretin amyloid cardiomyopathy | Circulation Top journal | 2026 | 0 |
| Screening for patients at risk for cardiac amyloidosis via electronic health records: A multicenter machine learning development and validation study. PMID 42848744 — electronic health records, machine learning, amyloidosis, records, learning, radionuclide imaging | PLOS Digit Health | 2026 | 0 |
| Prognostic Thresholds of Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy. PMID 42671012 — mortality, laboratories, cardiovascular diseases, cohort studies, prealbumin, echocardiography, amyloid, tricuspid valve insufficiency, cardiomyopathies, transthyretin amyloid cardiomyopathy | JAMA Cardiol | 2026 | 2 |
| Myocardial remodeling in valvular heart disease: pathophysiology, multimodality imaging and treatment implications. PMID 42527691 — heart valve diseases, heart diseases, heart failure, heart, therapeutics, mitral valve insufficiency, cardiomyopathies | Heart Fail Rev | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy Definition Prevalence and Prognostic Impact NCT06836011 — mitral valve, prealbumin, tricuspid valve, amyloidosis, prevalence, amyloid, tricuspid valve insufficiency, mitral valve insufficiency, prognosis, cardiomyopathies, transthyretin amyloid cardiomyopathy, transthyretin amyloidosis | N/A | Recruiting | 2025 |
| Aortic Stenosis and Cardiac Amyloidosis NCT06129331 — constriction, pathologic, aortic valve stenosis, aortic valve, amyloidosis, therapeutics, amyloid | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map